PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS

Allogeneic hematopoietic stem cell transplantation (HSCT) is curative treatment, albeit in a minority of patients with accelerated (AP) or blast phase (BP) chronic myeloid leukemia (CML). Imatinib (IM) has transient but significant activity in advanced phases of CML, which may permit early allograft...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khoury, Hanna J, Kukreja, Manisha, Goldman, John M., Wang, Tao, Halter, Jorg, Arora, Mukta, Gupta, Vikas, Rizzieri, David A., George, Biju, Keating, Armand, Gale, Robert Peter, Marks, David I., McCarthy, Philip L., Woolfrey, Ann, Szer, Jeffrey, Giralt, Sergio A., Maziarz, Richard T., Cortes, Jorge, Horowitz, Mary M., Lee, Stephanie J
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3896981/
https://ncbi.nlm.nih.gov/pubmed/21986636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.194
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados